Morning Overview on MSN
One-time gene-editing treatment lowers LDL cholesterol in early trial
A single infusion of a CRISPR-based gene-editing therapy was associated with reductions in LDL cholesterol and triglycerides ...
Editas Medicine announces USPTO reaffirms its prior decision in favour of the Broad Institute in CRISPR/Cas9 interference: Cambridge, Massachusetts Monday, March 30, 2026, 15:00 H ...
Morning Overview on MSN
Some bacteria use CRISPR-like tools to switch genes on
Researchers have found that certain bacteria carry a naturally occurring system, built from repurposed CRISPR components, ...
Most people who have heard of clustered regularly interspaced short palindromic repeats (more commonly known as CRISPR) associate it with gene editing—the precise molecular scissors that allow ...
Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for ...
Four faculty from the University of California, Davis, have been elected as Fellows of the American Association for the Advancement of Science, class of 2025. They are among nearly 500 scientists, ...
The MarketWatch News Department was not involved in the creation of this content. New Toolkit Allows Researchers to Test Potential Cancer Targets Directly in Patient-Leukemia Cells PHILADELPHIA, Feb.
PHILADELPHIA, Feb. 26, 2026 /PRNewswire/ -- A new CRISPR-based tool that is directly used on patients' cancer cells can identify genes and regulatory elements driving acute myeloid leukemia (AML), an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results